In vivokinetics of human apolipoprotein A-I variants in rabbits
- 1 March 1999
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 29 (3) , 196-203
- https://doi.org/10.1046/j.1365-2362.1999.00430.x
Abstract
Background Genetic variants of human apolipoprotein (apo) A‐I, the major protein component of high‐density lipoprotein (HDL), with a single amino acid substitution have been reported, and some of these result in very low plasma HDL‐cholesterol (C) levels. Examining the kinetics of radiolabelled apolipoprotein is a straightforward technique for determining its metabolism in vivo. In this study, we investigated the in vivo kinetics of several human apo A‐I variants, which we had identified previously, in rabbits. Materials and methods Apo A‐I variants from heterozygous carriers of Lys‐107→0, Lys‐107→Met, Pro‐3→Arg, Pro‐4→Arg, Pro‐165→Arg and Glu‐198→Lys and the corresponding normal apo A‐I were purified and then radioiodinated with 131I and 125I. A kinetic study of apo A‐I variants was performed in normolipidaemic rabbits after simultaneous injection of the two isotopes that had been incorporated into HDL. The fractional catabolic rate (FCR) was calculated from the radioactive decay curve. Results Acidic mature (negatively charged) apo A‐I variants caused by a single amino acid substitution (Lys‐107→0, and Lys‐107→Met) were catabolized faster (FCR, 1.931 ± 0.539 per day vs. 1.636 ± 0.460 per day, P ≤ 0.01 using the Wilcoxon signed‐rank test) and basic mature (positively charged) apo A‐I variants (Pro‐3→Arg, Pro‐4→Arg, Pro‐165→Arg and Glu‐198→Lys) were catabolized more slowly (FCR 1.470 ± 0.380 per day vs. 1.654 ± 0.430 per day, P ≤ 0.01) than the corresponding normal mature apo A‐I in vivo in rabbits. In addition, an inverse linear relationship was observed between the deviation in the FCR of variant human apo A‐I from that of normal human apo A‐I and the number of electric charges that the apo A‐I variant carried (r = –0.90, k = –0.188, P = 0.0003), as assessed by a linear regression analysis, suggesting that the electric charge of apo A‐I variants may determine, at least in part, its in vivo kinetics in rabbits. Conclusions Genetic variants of apo A‐I with a single amino acid substitution show abnormal kinetics, and the electric charge of a apo A‐I variant could contribute to determining its kinetics in vivo in this xenologous model.Keywords
This publication has 41 references indexed in Scilit:
- Apolipoprotein-mediated cellular cholesterol effluxBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic miceJournal of Lipid Research, 1998
- Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.Proceedings of the National Academy of Sciences, 1994
- Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.Journal of Clinical Investigation, 1994
- Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.Proceedings of the National Academy of Sciences, 1991
- Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.Journal of Clinical Investigation, 1989
- Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosisMetabolism, 1987
- Proapolipoprotein A-I conversion kinetics in vivo in human and in rat.Proceedings of the National Academy of Sciences, 1985
- Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.Journal of Lipid Research, 1985
- Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.Proceedings of the National Academy of Sciences, 1984